Analyst Recommendations

Wells Fargo analyst issues OVERWEIGHT recommendation for TMO on August 27, 2024 04:16PM ET. The previous analyst recommendation was Underweight.TMO was trading at $610.4 at issue of the...

August 27, 2024   TMO -2.72%

Wells Fargo analyst issues OVERWEIGHT recommendation for WAT on August 27, 2024 04:16PM ET. WAT was trading at $336.77 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   WAT -3.40%

Wells Fargo analyst issues OVERWEIGHT recommendation for AVTR on August 27, 2024 04:17PM ET. AVTR was trading at $25.61 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   AVTR -2.74%

Wells Fargo analyst issues OVERWEIGHT recommendation for EXAS on August 27, 2024 04:17PM ET. The previous analyst recommendation was Equal-Weight.EXAS was trading at $59.89 at issue of the...

August 27, 2024   AVTR -2.74%

Wells Fargo analyst issues OVERWEIGHT recommendation for MYGN on August 27, 2024 04:17PM ET. MYGN was trading at $27.5 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   MYGN -4.66%

Wells Fargo analyst issues OVERWEIGHT recommendation for MRVI on August 27, 2024 04:18PM ET. MRVI was trading at $9.03 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   MRVI -4.19%

Wells Fargo analyst issues OVERWEIGHT recommendation for BRKR on August 27, 2024 04:18PM ET. BRKR was trading at $63.95 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   BRKR -3.23%

Wells Fargo analyst issues UNDERWEIGHT recommendation for CDNA on August 27, 2024 04:19PM ET. CDNA was trading at $31.8 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   CDNA -3.72%

Wells Fargo analyst issues UNDERWEIGHT recommendation for MLAB on August 27, 2024 04:19PM ET. MLAB was trading at $140.86 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   MLAB 0.31%

Wells Fargo analyst issues OVERWEIGHT recommendation for RGEN on August 27, 2024 04:18PM ET. RGEN was trading at $146.03 at issue of the analyst recommendation.The overall analyst consensus...

August 27, 2024   RGEN -3.66%